# MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease

> **NIH NIH K01** · EMORY UNIVERSITY · 2021 · $100,781

## Abstract

PROJECT SUMMARY/ABSTRACT
The goal of this NIDDK Mentored Research Scientist Career Development (K01) Award is to provide funding
for the principal investigator (PI), Dr. Manoj Thapa, developing into an independent biomedical research
scientist in the field of liver disease and liver immunology. After joining the Dr. Arash Grakoui’s laboratory at
Yerkes National Primate Research Center of Emory University, the PI initiated a new project with the intention
of identifying factors that lead to T and B cell differentiation during liver disease. In this K01 proposal, PI will
build upon his previous expertise and study the dynamics of cellular immune responses focusing on the
mechanisms of B cell dysregulations during chronic liver diseases associated with chronic hepatitis C virus
(HCV) infection, alcohol liver disease (ALD) and nonalcoholic steatohepatitis (NASH). PI will be allocating 75%
of his time for the research as proposed in this K01 application and 25% of the time to didactic trainings such
as participation in seminars, lab meetings, manuscript preparation, grant writing, and national and international
conferences.
This project will focus on the contribution of MyD88-specific toll like receptor (TLR) activation and BAFF/BLyS
signaling in the B cell-mediated pathogenesis of liver disease and autoimmune disorder. The incidence of end-
stage liver disease (ESLD) is increasing in the United States and poses a serious economic and clinical burden
as it is expected to afflict more than 300 million individuals worldwide. Chronic HCV infection, ALD, and NASH
account for the majority of ESLD cases, with chronic HCV associated with the highest incidence of liver
transplantation. The orthotopic liver transplantation is the optimal treatment for ESLD and carries a high cost
while benefitting relatively few. Understanding the mechanisms of the cellular immune responses that
contributes to fibrosis and the progression of ESLD is critical for effective therapeutic intervention. PI will
approach these questions from two different directions. First, by using murine models of experimental liver
fibrosis, PI will delineate the role of MyD88-specific TLR signaling and BAFF/BLyS signaling in B cell
dysfunction, liver fibrosis and autoimmune disorder associated with liver disease. Then, he will build his career
into human translational science to improve an understanding of cellular immune response in human chronic
liver diseases including HCV, ALD and NASH patients. These diseases while different have common themes
(i.e. fibrosis/cirrhosis) and therefore proposed in this study to compare and contrast the effect of a viral
infection (HCV), an inflammation without infection (NASH) and the absence of virus and an on-going
inflammatory insult at the time of transplant (ALD) (alcohol abstinence is required for a minimum of 6 months
prior to transplant at Emory Transplant Center) on B cell activation and function. The application will provide an
immunological basis for...

## Key facts

- **NIH application ID:** 10107808
- **Project number:** 5K01DK109025-05
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Manoj Thapa
- **Activity code:** K01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $100,781
- **Award type:** 5
- **Project period:** 2017-03-16 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10107808

## Citation

> US National Institutes of Health, RePORTER application 10107808, MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease (5K01DK109025-05). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10107808. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*